Welcome to the July newsletter. This newsletter aims to provide information and analysis of timely topics from recent articles published in the medical literature. I hope you find this information useful and helpful in your health journey. If you have comments or questions, please let us know!
The Delta variant has become more prevalent. This variant seems to be causing more problems for people who are vaccinated than previous versions. However, despite breathless media reports, as of July 19, the CDC had received reports of 5,914 COVID-19-related hospitalizations and deaths out of more than 161 million fully vaccinated people in the United States. That is around 3/100,000 vaccinated people ending up hospitalized (all comers) and certainly, those with few risk factors (higher age, immunocompromised status, obesity) are at much lower risk. Vaccination takes the risk of an 80-year-old to that of a healthy 50-year-old, and 50-year-olds are now at similar risk to 20-year-olds. Vaccination continues to be the best way moving forward and these vaccines are still remarkably effective. This will likely be a wave similar to others (around 12 weeks). Note that India is now back to near baseline prior to their surge of Delta from mid-March to mid-June.
I am happy to announce that I have secured access to one of the newest diagnostic tests available. The Galleri test is a blood test that can detect over 50 types of cancer before they are apparent through regular screening testing (and many cancers don't have a screening test). The test detects methylation patterns of cell-free DNA which can indicate cancer and thus has the potential to detect cancer at the earliest stages. If you are interested in learning more about this test please let us know.